CN1426790A - 林蛙油软胶囊 - Google Patents
林蛙油软胶囊 Download PDFInfo
- Publication number
- CN1426790A CN1426790A CN01138864A CN01138864A CN1426790A CN 1426790 A CN1426790 A CN 1426790A CN 01138864 A CN01138864 A CN 01138864A CN 01138864 A CN01138864 A CN 01138864A CN 1426790 A CN1426790 A CN 1426790A
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- frog oil
- forest frog
- oil soft
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007901 soft capsule Substances 0.000 title claims description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 9
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- 241000191896 Rana sylvatica Species 0.000 claims description 9
- 210000003101 oviduct Anatomy 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 241001122767 Theaceae Species 0.000 claims description 5
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 235000008524 evening primrose extract Nutrition 0.000 abstract 1
- 229940089020 evening primrose oil Drugs 0.000 abstract 1
- 239000010475 evening primrose oil Substances 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 8
- 230000033228 biological regulation Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000032683 aging Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000269436 Ranidae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003172 anti-dna Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- -1 hydroxyl hydrogen Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种林蛙油软胶囊的配方，它由月见草油、林蛙油、维生素E、茶多酚等多种天然物质科学配制加工而成的，该产品具有营养价值高、延缓衰老、调节血脂保健功能。
Description
技术领域：本发明涉及一种营养保健品，特别是涉及林蛙油与月见草
油等混合配制的林蛙油软胶囊。
背景技术；林蛙俗称哈士蟆，是一个地药用价值、营养价值、社会价
值和生态效益等方面，都具有重要经济意义的两栖类蛙科
动物，它干燥输卵管——哈士蟆油是中国东北特产的一种
弛名中外的名贵食疗性中药，国际市场上被誉名为“软黄
金”。中医药学认为林蛙油具有：滋阴补肾，补虚损。用
于肾阴虚所致腰膝酸软、五心烦热，病后、产后体弱等。
然而，上述产品人们直接食用或用干燥林蛙油泡水服用，
具有口感差、其中的不饱和脂肪酸易被氧化，易酸败，同
时，贮存不便。
技术内容：本发明的目的在于克服上述不足之处，提供一种配方合理，
易加工，服用口感好，便于人体吸收的林蛙油软胶囊配方。为了达到上述目的，本发明采用的技术方案是：月见草油 40％～80％林蛙油 10％～40％维生素E 5％～10％茶多酚 5％～10％
具体实施方案：下面对本发明实施例作详细的描述：实例1：
月见草油 40g
林蛙油 40g
维生素E 10g
茶多酚 10g实例2：
月见草油 80g
林蛙油 10g
维生素E 5g
茶多酚 5g实例3：
月见草油 50g
林蛙油 30g
维生素E 10g
茶多酚 10g
林蛙油软胶囊主要原料林蛙油中含有大量的不饱和脂肪酸可以有效地使血清总胆固醇、甘油三酯浓度下降，高密度脂蛋白升高；有效的调节血脂，改善血液粘度，降低血栓，恢复血管壁弹性。***、孕酮和激素类是与人体内产生的激素类完全相同的天然激素，能调节内分泌***，促进新陈代谢，提高机体免疫力，对于绝经前后的中老年妇女，在调节内分泌***、抗衰老、强体魄等方面起很大的作用；而其最为突出的是所含50％以上蛋白质及40％以上的氨基酸可以使肌肉更加坚实，消除因蛋白质不足引起的憔悴，增强皮肤的弹性，促进机体的生长发育，快速地营养、滋润细胞。从而发挥疲劳、抗衰老功效。本产品中所配用的天然油脂抗氧化剂——茶多酚一类氧化还原电位很低的还原剂具有活泼的羟基氢，能提供氢质子与体内过量的自由基结合，在消除活性氧自由基，表现出特异的功能。实验结果证明茶多酚对过氧化氢诱导的DNA链断裂具有明显的抑制作用，表明茶多酚具有抗DNA氧化损伤作用；次外，在调节血脂方面起到很大的作用，一方面能明显降低血清胆固醇，LDL含量及升高HDL含量，且对TC、LDL有明显的量效关系；另一方面促进脂类化合物从粪便中排出，既能防治动脉粥样硬化又有减肥的效果。与维生素C和维生素E配合还可增强作用。
林蛙油软胶囊中的另一成分维生素E，可以减少自由基的存在和过氧化酯质的增多，可防止脑细胞老化，促进脑细胞活力，延缓衰老性疾病的发生与发展。众所周知，人在利用氧时会副生“活性氧”，成为氧毒—游离基，损害生物体。游离基能促使脂肪过度氧化，细胞膜和细胞内部结构发生损害，是已知许多中老年疾病，如缺血、动脉硬化、肾炎、肝功能障碍、癌症、糖尿病、白内障、风湿病以及各种炎症等的诱因。维生素E有很强的抗氧化能力，可阻止细胞氧化损伤、延缓人体细胞染色体的***过程、维持细胞功能完整、延长细胞寿命、延缓人体衰老。还可以消除组织中的衰老色素脂褐素，降低血胆固醇浓度，抑制动脉硬化的作用，还有保护毛细管，改善微循环和皮肤弹性，预防白内障等
综上所述，林蛙油软胶囊配比科学，功效独特，各组分在协同作用的同时又能增强相互疗效，是调节血脂、延缓衰老最佳产品。
Claims (1)
1、一种林蛙油软胶囊的配方，其特征在于：以下各组分按重量百分比计：月见草油 40％～80％林蛙油 10％～40％维生素E 5％～10％茶多酚 5％～10％
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011388641A CN1248597C (zh) | 2001-12-21 | 2001-12-21 | 林蛙油软胶囊 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011388641A CN1248597C (zh) | 2001-12-21 | 2001-12-21 | 林蛙油软胶囊 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1426790A true CN1426790A (zh) | 2003-07-02 |
| CN1248597C CN1248597C (zh) | 2006-04-05 |
Family
ID=4674816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011388641A Expired - Fee Related CN1248597C (zh) | 2001-12-21 | 2001-12-21 | 林蛙油软胶囊 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1248597C (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100415215C (zh) * | 2005-11-11 | 2008-09-03 | 江西金海棠药用油有限公司 | 一种野山茶油软胶囊 |
| CN101120951B (zh) * | 2006-08-10 | 2010-05-12 | 孙欣 | 润巢软胶囊及其制作方法 |
| CN102948663A (zh) * | 2012-12-19 | 2013-03-06 | 刘书新 | 一种林蛙油颗粒剂及其制备方法 |
| CN103005460A (zh) * | 2012-12-04 | 2013-04-03 | 吉林博大农林生物科技有限公司 | 一种林蛙油抗衰老食品 |
| CN105596424A (zh) * | 2016-02-04 | 2016-05-25 | 张菊明 | 哈桑抗压平衡养生胶囊及其制备方法 |
-
2001
- 2001-12-21 CN CNB011388641A patent/CN1248597C/zh not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100415215C (zh) * | 2005-11-11 | 2008-09-03 | 江西金海棠药用油有限公司 | 一种野山茶油软胶囊 |
| CN101120951B (zh) * | 2006-08-10 | 2010-05-12 | 孙欣 | 润巢软胶囊及其制作方法 |
| CN103005460A (zh) * | 2012-12-04 | 2013-04-03 | 吉林博大农林生物科技有限公司 | 一种林蛙油抗衰老食品 |
| CN102948663A (zh) * | 2012-12-19 | 2013-03-06 | 刘书新 | 一种林蛙油颗粒剂及其制备方法 |
| CN105596424A (zh) * | 2016-02-04 | 2016-05-25 | 张菊明 | 哈桑抗压平衡养生胶囊及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1248597C (zh) | 2006-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101373636B1 (ko) | 천연물 복합 발효 추출물을 유효성분으로 하는 피부 및 두피 상태 개선용 조성물 | |
| CN102078283A (zh) | 一种中药美白祛斑营养乳膏 | |
| CN104825347B (zh) | 一种医用生物美白袪斑敷料及其制备方法 | |
| CN103432063B (zh) | 一种用于治疗青春痘色素沉斑和美白的精华液 | |
| CN103417462B (zh) | 一种用于治疗青春痘色素沉斑和美白的面膜 | |
| CN101791285B (zh) | 一种用于清除面部老年斑的黄皮酰胺复合纳米乳及其制备方法 | |
| KR101374277B1 (ko) | 천연물 복합 발효 추출물을 유효성분으로 하는 발모제 조성물 | |
| CN105267717A (zh) | 具有多重化妆品功效的天然草本植物药液及其应用 | |
| CN101401779A (zh) | 含有复合植物多酚提取物的化妆品组合物及其制备方法 | |
| CN102960602A (zh) | 一种芦荟保健粉 | |
| CN103432064B (zh) | 一种用于治疗青春痘色素沉斑和美白的膏霜 | |
| CN1248597C (zh) | 林蛙油软胶囊 | |
| RU2283124C1 (ru) | Биологически активный препарат на основе морского растительного сырья | |
| CN105963674A (zh) | 一种天然细胞修复剂及其制备方法 | |
| CN105534858A (zh) | 植物精华粉及面膜霜和面膜粉 | |
| CN102008083A (zh) | 一种缓解体力疲劳、祛黄褐斑的保健食品 | |
| CN107441340B (zh) | 一种消肿止痛止痒滋养皮肤的手足皴裂膏及其制备方法 | |
| CN103932941A (zh) | 营养元素抗衰护肤液 | |
| CN101297705B (zh) | 复方藏羊胎素祛皱抗衰胶囊 | |
| CN106937923A (zh) | 灵芝花粉护肤防衰霜 | |
| CN102919853A (zh) | 林蛙油软胶囊 | |
| CN109646359B (zh) | 一种具有清洁净化和美容养颜功效的玫瑰木耳泥膜膏及其制备方法 | |
| CN103860430B (zh) | 一种美容面膜及其制备方法 | |
| CN113876676A (zh) | 一种石斛养颜霜及其制备方法 | |
| CN102948663A (zh) | 一种林蛙油颗粒剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING YISHOUTANG HEALTH TECHNOLOGY CO.,LTD. Free format text: FORMER OWNER: HARBIN JIANKANGREN SCIENCE AND SCIENCE CO. LTD. Effective date: 20050513 |
|
| C10 | Entry into substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20050513 Address after: No. 36, water source road, Miyun Industrial Development Zone, Beijing Applicant after: Beijing Yishoutang Healthcare Technology Co. Ltd. Address before: 150090 No. 20, Harbin hi tech Development Zone, Nangang District, Heilongjiang, Hengshan Road Applicant before: Harbin Jiankangren Science and Science Co. Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HARBIN RED SUN HEALTH INDUSTRY GROUP CO., LTD. Free format text: FORMER OWNER: BEIJING YISHOUTANG HEALTH TECHNOLOGY CO.,LTD. Effective date: 20090612 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20090612 Address after: Zip code at Bohai road and Weihai Road, Harbin, China: 150069 Co-patentee after: Yishoutang Health Technology Industry Co. Ltd. Patentee after: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. Address before: No. 36, water source road, Miyun Industrial Development Zone, Beijing, China: 101500 Patentee before: Beijing Yishoutang Healthcare Technology Co. Ltd. |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Baoshan Document name: Notification of Passing Examination on Formalities |
|
| DD01 | Delivery of document by public notice |
Addressee: Wang Baoshan Document name: Notification of Termination of Patent Right |
|
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: YISHOU HALL HEALTH SCIENCE AND TECHNOLOGY INDUSTRY CO., LTD. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20110126 Address after: 150069 Bohai road and Weihai Road intersection, cottage District, Harbin Patentee after: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. Address before: 150069 Bohai road and Weihai Road intersection, cottage District, Harbin Co-patentee before: Yishoutang Health Technology Industry Co. Ltd. Patentee before: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Baoguang Document name: Notification to Pay the Fees |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060405 Termination date: 20171221 |